Medial prefrontal cortical injections of c-Fos antisense oligonucleotides transiently lower c-fos protein and mimic amphetamine withdrawal behaviours

Neuroscience

Volumn 82, Issue 4, 1997, Pages 1115-1129

  Persico, A M ^a,c   Schindler, C W ^a   Davis, S C ^a   Ambrosio, E ^a,d   Uhl, G R ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTISENSE OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ARTICLE; DOWN REGULATION; DRUG WITHDRAWAL; GENE EXPRESSION REGULATION; MALE; NONHUMAN; ONCOGENE C FOS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; RAT; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

EID: 0343923614     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00248-0     Document Type: Article

References (81)

1. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. molec. Biol. 215:1990;403-410.
2. Asanuma M., Ogawa N., Hirata H., Chou H., Tanaka K., Mori A. Opposite effects of rough and gentle handling with repeated saline administration on c-fos mRNA expression in the rat brain. J. neural Transm. 90:1992;163-169.
3. Baxter L. R. Jr., Schwartz J. M., Phelps M. E., Mazziotta J. C., Guze B. H., Selin C. E., Gerner R. H., Sumida R. M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archs gen. Psychiat. 46:1989;243-250.
4. Blanar M. A., Rutter W. J. Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos. Science. 256:1992;1014-1018.
5. Campeau S., Hayward M. D., Hope B. T., Rosen J. B., Nestler E. J., Davis M. Induction of the c-fos protooncogene in rat amygdala during unconditioned and conditioned fear. Brain Res. 565:1991;349-352.
6. Chavany C., Connell Y., Neckers L. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Molec. Pharmac. 48:1995;738-746.
7. Chiang M.-Y., Chan H., Zounes M. A., Freier S. M., Lima W. F., Bennett C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. biol. Chem. 266:1991;18162-18171.
8. Chiasson B. J., Hooper M. L., Murphy P. R., Robertson H. A. Antisense oligonucleotide eliminates in vivo espression of c-fos in mammalian brain. Eur. J. Pharmac. 227:1992;451-453.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162:1987;156-159.
10. Clow D. W., Hammer R. P. Jr. Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions - bromocriptine enhances recovery. Neuropsychopharmacology. 4:1991;71-75.
11. Copple B. L., Gmeiner W. M., Iversen P. L. Reaction between metabolically activated acetaminophen and phosphorothioate oligonucleotides. Toxicol. appl. Pharmac. 133:1995;53-63.
12. Crook S. T. Therapeutic applications of oligonucleotides. A. Rev. Pharmac. Toxicol. 32:1992;329-376.
13. Curran T., Gordon M. B., Rubino K. L., Sambucetti L. C. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modifications in vitro. Oncogene. 2:1987;79-84.
14. Dai G., Levy O., Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature. 379:1996;458-460.
15. Davis S. C., Tzagoloff A., Ellis S. R. Characterization of a yeast mitochondrial ribosomal protein structurally related to the mammalian 68 kDa high affinity laminin receptor. J. biol. Chem. 267:1992;5508-5514.
16. Deutch A. Y., Roth R. H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog. Brain Res. 85:1990;357-393.
17. Diamond M. I., Miner J. N., Yoshinaga S. K., Yamamoto K. R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science. 249:1990;1266-1272.
18. Dragunow M., Lawlor P., Chiasson B. J., Robertson H. A. C-fos antisense generates apomorphine and amphetamine-induced rotation. NeuroReport. 5:1993;305-306.
19. Dupont W. D., Plummer W. D. Jr. Power and sample size - a review and computer program. Controlled Clin. Trials. 11:1990;116-128.
20. Dworkin S. I., Smith J. E. Cortical regulation of self-administration. Ann. N. Y. Acad. Sci. 654:1992;274-281.
21. Fagarasan M. O., Aiello F., Muegge K., Durum S., Axelrod J. Interleukin 1 induces β-endorphin secretion via Fos and Jun in AtT-20 pituitary cells. Proc. natn. Acad. Sci. U.S.A. 87:1990;7871-7875.
22. Gawin F. H. Cocaine addiction: psychology and neurophysiology. Science. 251:1991;1580-1586.
23. Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Archs gen. Psychiat. 43:1986;107-113.
24. 3H-DOPA at various regions of the brain. J. Neurochem. 13:1966;665-669.
25. Grassi-Zucconi G., Menegazzi M., Carcerari de Prati A., Bassetti A., Montagnese P., Mandile P., Cosi C., Bentivoglio M. c-fos mRNA is spontaneously induced in the rat brain during the activity period of the circadian cycle. Eur. J. Neurosci. 5:1993;1071-1078.
26. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. natn. Acad. Sci. U.S.A. 88:1991;3720-3724.
27. Hanukoglu I., Tanese N., Fuchs E. Complementary DNA sequence of a human cytoplasmic actin: interspecies divergence of 3′ non-coding regions. J. molec. Biol. 163:1983;673-678.
28. Heilig M., Engel J. A., Soderpalm B. C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur. J. Pharmac. 236:1993;339-340.
29. Heilig M. and Schlingensiepen K. H. (1996) Antisense oligodeoxynucleotides as novel neuropharmacological tools for selective expression blockade in the brain. In Genetic Manipulation of the Nervous System (ed. Latchman D. S.), pp. 249-268. Academic Press, London.
30. Hertl M., Neckers L. M., Katz S.I. Inhibition of interferon-γ-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects. J. invest. Dermat. 104:1995;813-818.
31. Hooper M. L., Chiasson B. J., Robertson H. A. Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of Fos and produces a behavioral effect. Neuroscience. 63:1994;917-924.
32. Jain J., McCaffrey P. G., Miner Z., Kerppola T. K., Lambert J. N., Verdine G. L., Curran T., Rao A. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature. 365:1993;352-356.
33. Javsik G. E., Karoum F., Weinberger D. R. Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex. Brain Res. 534:1990;321-323.
34. Johnson R. S., Spiegelman B. M., Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 71:1992;577-586.
35. Kokkinidis L. (1988) Neurochemical correlates of post-amphetamine depression and sensitization in animals. In Animal Models of Psychiatric Disorders (eds Simon P., Soubrie' P., Widlocher D.), Vol. 2, pp. 148-173. Karger, Basel.
36. Kokkinidis L., Zacharko R. M., Predy P.A. Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants. Pharmac. Biochem. Behav. 13:1980;379-383.
37. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. molec. Biol. 196:1987;947-950.
38. Kramer J. C., Fischman V. S., Littlefield D. C. Amphetamine abuse - patterns and effects of high doses taken intravenously. J. Am. med. Ass. 201:1967;305-309.
39. Leith N. J., Barrett R. J. Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacology. 46:1976;19-25.
40. Lipska B. K. and Weinberger D. R. (1993) Cortical regulation of the mesolimbic dopamine system: implications for schizophrenia. In Limbic Motor Circuits and Neuropsychiatry (eds Kalivas P. W. and Barnes C. D.), pp. 329-372. CRC Press, Boca Raton.
41. Lucibello F. C., Slater E. P., Jooss K. U., Beato M., Muller R. Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. Eur. molec. Biol. Org. J. 9:1990;2827-2834.
42. Marota J. J. A., Crosby G., Uhl G. R. Selective effects of pentobarbital and halothane on c-fos and jun-B gene expression in rat brain. Anesthesiology. 77:1992;365-371.
43. Martinot J. L., Hardy P., Feline A., Huret J. D., Mazoyer B., Attar-Levy D., Pappata S., Syrota A. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am. J. Psychiat. 147:1990;1313-1317.
44. Moller C., Bing O., Heilig M. C-fos expression in the amygdala: in vivo antisense modulation and role in anxiety. Cell. molec. Neurobiol. 14:1994;415-423.
45. Neckers L., Whitesell L., Rosolen A., Geselowitz D. A. Antisense inhibition of oncogene expression. Crit. Rev. Oncogen. 3:1992;175-231.
46. Pang Y., Kiba H., Jayaraman A. Acute nicotine injections induce c-fos mostly in non-dopaminergic neurons of the midbrain of the rat. Molec. Brain Res. 20:1993;162-170.
47. Paulson P. E., Camp D. M., Robinson T. E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103:1991;480-492.
48. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
49. Paylor R., Johnson R. S., Papaioannou V., Spiegelman B. M., Wehner J. M. Behavioral assessment of c-fos mutant mice. Brain Res. 651:1994;275-282.
50. Persico A. M., Schindler C. W., O'Hara B. F., Brannock M. T., Uhl G. R. Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Molec. Brain Res. 20:1993;91-100.
51. Persico A. M., Schindler C. W., Brannock M. T., Gonzalez A. M., Surratt C. K., Uhl G. R. Dopaminergic gene expression during amphetamine withdrawal. NeuroReport. 4:1993;41-44.
52. Persico A. M., Schindler C. W., Zaczek R., Brannock M. T., Uhl G. R. Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress. Synapse. 19:1995;212-227.
53. Persico A. M. and Uhl G. R. (1997) Transcription factors: potential roles in drug-induced neuroplasticity. Rev. Neurosci. (in press).
54. Piazza P. V., Rouge-Pont F., Deminiere P. V., Kharoubi M., le Moal M., Simon S. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567:1991;169-174.
55. Rimondini R., Sommer W., O'Connor W. T., Hansson A., Fuxe K., Ungerstedt U. Intrastriatal c-fos antisense oligonucleotide decreases GABA release in the substantia nigra but not in the globus pallidus. An in vivo microdyalisis study in the awake rat. Soc. Neurosci. Abstr. 21:1995;1375.
56. Sambrook J., Fritsch E. F. and Maniatis T. (1989) Molecular Cloning - A Laboratory Manual (2nd edn). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
57. Sanna P. P., Weiss F., Samson M. E., Bloom F. E., Merlo Pich E. Rapid induction of tumor necrosis factor α in the cerebrospinal fluid after intracerebroventricular injection of lipopolysaccharide revealed by a sensitive capture immuno-PCR assay. Proc. natn. Acad. Sci. U.S.A. 92:1995;272-275.
58. Schildkraut J. J., Watson R., Draskoczy P. R., Hartmann E. Amphetamine withdrawal: depression and M.H.P.G. excretion. Lancet. 2:1971;485-486.
59. Schindler C. W., Persico A. M., Uhl G. R., Goldberg S. R. Behavioral assessment of high-dose amphetamine withdrawal:importance of training and testing conditions. Pharmac. Biochem. Behav. 49:1994;41-46.
60. Schreiber H., Bell R., Conely L., Kufner M., Palet J., Wright L. Diminished reaction to a novel stimulus during amphetamine withdrawal in rats. Pharmac. Biochem. Behav. 5:1976;687-690.
61. Sommer W., Bjelke B., Ganten D., Fuxe K. Antisense oligonucleotide to c-fos induced ipsilateral rotational behaviour to D-amphetamine. NeuroReport. 5:1993;277-280.
62. Spampinato S., Canossa M., Carboni L., Campana G., Leanza G., Ferri S. Inhibition of proopiomelanocortin expression by an olideoxynucleotide complementary to β-endorphin mRNA. Proc. natn. Acad. Sci. U.S.A. 91:1994;8072-8076.
63. Srinivasan S. K., Tewary H. K., Iversen P. L. Characterization of binding sites, extent of binding and drug interactions of oligonucleotides with albumin. Antisense Res. Dev. 5:1995;131-139.
64. Stein C. A., Chieng Y. C. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science. 261:1993;1004-1012.
65. Straaten F. V., Muller R., Curran T., Van Beveren C., Verma I.M. Complete nucleotide sequence of a human c-onc gene: Deduced amino acid sequence of the human c-fos protein. Proc. natn. Acad. Sci. U.S.A. 80:1983;3183-3187.
66. Touray M., Ryan F., Jaggi R., Martin F. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun. Oncogene. 6:1991;1227-1234.
67. Uhl G. R., Zingg H. H., Habener J. F. Vasopressin mRNA in situ hybridization: localization and regulation studied with oligonucleotide cDNA probes in normal and Brattleboro rat hypothalamus. Proc. natn. Acad. Sci. U.S.A. 82:1985;5555-5558.
68. Van den Bergh S., Kaina B., Rahmsdorf H. J., Ponta H., Herrlich P. Involvement of fos in spontaneous and ultraviolet light-induced genetic changes. Molec. Carcinogenesis. 4:1991;460-466.
69. Vandenbergh D. J., Mori N., Anderson D. J. Co-expression of multiple neurotransmitter enzyme genes in normal and immortalized sympathoadrenal progenitor cells. Devl Biol. 148:1991;10-22.
70. Volkow N. D., Fowler J. S., Wolf A. P., Hitzemann R., Dewey S., Bendriem B., Alpert R., Hoff A. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am. J. Psychiat. 148:1991;621-626.
71. Wahlestedt C., Golanov E., Yamamoto S., Yee F., Ericson H., Yoo H., Inturrisi C. E., Reis D. J. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischemic infarctions. Nature. 363:1993;260-263.
72. Wahlestedt C. Antisense oligonucleotide strategies in neuropharmacology. Trends pharmac. Sci. 15:1994;42-46.
73. Watson R., Hartmann E., Schildkraut J. J. Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am. J. Psychiat. 129:1972;39-45.
74. Weiss B., Zhou L. W., Zhang S. P., Qin Z. H. Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA. Neuroscience. 55:1993;607-612.
75. Whitesell L., Geselowitz D., Chavany C., Fahmy B., Walbridge S., Alger J. R., Neckers L. M. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proc. natn. Acad. Sci. U.S.A. 90:1993;4665-4669.
76. Wickstrom E. Oligodeoxynucleotide stability in subcellular extracts and culture media. J. biochem. biophys. Meth. 13:1986;97-102.
77. Willner P. Animal models of depression: an overview. Pharmac. Ther. 45:1990;425-455.
78. Willner P., Sampson D., Papp M., Phillips G. and Muscat R. (1990) Animal models of anhedonia. In Animal Models of Psychiatric Disorders (eds Simon P., Soubrie' P., Widlocher D.), Vol. 3, pp. 71-99. Karger, Basel.
79. Wollnik F., Brysch W., Uhlmann E., Gillardon F., Bravo R., Zimmermann M., Schlingensiepen K. H., Herdegen T. Block of c-Fos and JunB expression by antisense oligonucleotides inhibits light-induced phase shifts of the mammalian circadian clock. Eur. J. Neurosci. 7:1995;388-393.
80. Woolf T. M., Melton D. A., Jennings C. G. B. Specificity of antisense oligonucleotides in vivo. Proc. natn. Acad. Sci. U.S.A. 89:1992;7305-7309.
81. Yaswen P., Stampfer M. R., Ghosh K., Cohen J. S. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res. Dev. 3:1993;67-77.